Merck-backed Quartet places biotech vet Gerhard Koenig at the helm
Gerhard Koenig has landed the top job at Quartet Medicine, just a few months after Merck grabbed a buyout option in its $575 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.